Skip to content
Home » News » Science VS Sars-Cov-2: Science Could Win

Science VS Sars-Cov-2: Science Could Win

    We all know that 2021 will go into almost everyone’s history book as the vaccine year against the COVID-19 pandemic. It made us realize why science is key to understanding viruses, bacteria and the interactions between humans and their environment. We from TCS are leveraging our full human immune system mouse models and knowledge to assist our customers in the fight against SARS-Cov2, HIV, and other infectious diseases in our state-of-the-art BSL2 and 3 animal and lab facilities.

    They trusted us for their projects: Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models from PepTC Vaccines Ltd., Treos Bio Zrt